Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-γ

Immunology

Volumn 93, Issue 4, 1998, Pages 556-562

  Smith, R E ^a   Donachie, A M ^a   Mclaren, F H ^a   Mowat, A McI ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CONCANAVALIN A; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; INTERLEUKIN 5; ISCOM; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PHOSPHATIDYLCHOLINE; QUIL A; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; CELL DIVISION; CYTOKINES; HYPERSENSITIVITY, DELAYED; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERLEUKIN-4; ISCOMS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031946347     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00469.x     Document Type: Article

References (47)

1. + cell responses by oral or parenteral immunisation with ISCOMS. Eur J Immunol 25, 2835.
2. MOWAT A.MCI., DONACHIE A.M., REID G. & JARRETT O. (1991) Immune stimulating complexes containing Quil-A and protein antigen prime class I MHC restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72, 317.
3. KAZANJI M., LAURENT F. & PERRY P. (1994) Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria falciformis in ISCOMs. Vaccine 12, 798
4. ESTRADA A., LAARVELD B., LI B. & REDMOND M.J. (1995) Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS. Imm Invest 24, 819.
5. MOREIN B. (1990) The ISCOM: An immunostimulating system. Immunol Lett 25, 281.
6. + cytotoxic T lymphocytes towards soluble antigens: Immunostimulating-ovalbumin complexes enter the Class I MHC-restricted antigen pathway and allow sensitisation against the immunodominant peptide. Eur J Immunol 21, 1523.
7. MOWAT A.MCI., MALOY K.J. & DONACHIE A.M. (1993) Immune stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunisation with protein antigens. Immunology 80, 527.
8. MOWAT A.MCI. (1987) The regulation of immune responses to dietary protein antigens. Immunol Today 8, 93.
9. GUPTA R.K. & SIBER G.R. (1995) Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13, 1263.
10. KHORUTS A. & JENKINS M.K. (1996) Studying immunological tolerance by physically monitoring antigen-specific T cells in vivo. Ann NY Acad Sci 778, 72.
11. 2 like cells in vitro is interleukin-4 dependent and inhibited by interferon gamma. Immunology 79, 562.
12. 1 like responses. Inject Immun 62, 5498.
13. LE GROS G., BEN-SASSON S.Z., SEDER R., FINKELMAN F.D. & PAUL W.E. (1990) Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J Exp Med 172, 921.
14. VAJDY M., KOSCO-VILBOIS, KOPF M., KÖHLER G. & LYCKE N. (1995) Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 181, 41.
15. MAGGI E.P., PARRONCHI R., MANETTI C. et al. (1992) Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148, 2142.
16. SCOTT P. & KAUFMAN S.H.E. (1991) The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 12, 346.
17. BUCHMEIER N.A. & SCHREIBER R.D. (1985) Requirement for endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 82, 7404.
18. SCOTT P. (1991) IFNγ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147, 3149.
19. SCHIJNS V.E.C., HAAGMANS B.L., RIJKE E.O., HUANG S., AGUET M. & HORZINEK M.C. (1994) IFNγ receptor-deficient mice generate antiviral th1-characteristic cytokine profiles but altered antibody responses. J Immunol 153, 2029.
20. GARSIDE P., STEEL M., WORTHEY E. et al. (1995) Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 154, 5649.
21. ELSON C.O., EALDING W. & LEFKOWITZ J. (1984) A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods 67, 101.
22. TAKAHASHI H., TAKASHITA T., MOREIN B., PUTNEY S., GERMAIN R.N. & BERZOFSKY, J.A. (1990) Induction of CD8+ cytotoxic T-cells by immunisation with purified HIV-1 envelope protein in ISCOMS. Nature 344, 873.
23. TRUDEL M., NADON F., SEGUIN C., BRAULT S., LUSIGNAN Y. & LEMIEUX S. (1992) Induction cytotoxic T-cell response and protection of BALB/c mice by vaccination with an experimental ISCOMS respiratory sincitial virus subunit vaccine. Vaccine 10, 107.
24. KÜHN R., RAJEWSKY K. & MULLER W. (1991) Generation and analysis of interleukin-4 deficient mice. Science 254, 707.
25. VON DER WIELD T., KOPF M., KÖHLER G. & LANGHORNE J. (1994) The immune response to Plasmodium chabaudi malaria in interleukin -4-deficient mice. Eur J Immunol 24, 2285.
26. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun 64, 1516.
27. KOPF M., LE GROS G., BACHMANN M., LAMERS M.C., BLUETHMANN H. & KOHLER G. (1993) Disruption of the murine IL-4 gene blocks TH2 cytokine responses. Nature 362, 245.
28. LIANG S.M., LEE N., FINBLOOM D.S. & LIANG C.M. (1992) Regulation by glutathione of interleukin-4 activity on cytotoxic T cells. Immunology 75, 435.
29. + cells and their role in the generation of antigen-specific cytotoxic T cells. Eur J Immunol 21, 1863.
30. LEY V., LONGLADE DEMOYEN P., KOURILSKY P. & LARSSON SCIARD E.L. (1991) Interleukin 2-dependent activation of tumour-specific cytotoxic T lymphocytes in vivo. Eur J Immunol 21, 851.
31. ROTH A.D., HORNICEK F.J. & GERSTNER C.G. (1991) Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma. Clin Exp Immunol 86, 163.
32. YE W., ZHENG I.M., YOUNG J.D.E. & LIU C.C. (1996) The involvement of interleukin (IL)-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant utuerus. J Exp Med 184, 2405.
33. MURRAY P.D., MCKENZIE D.T., SURAIN S.L. & KAGNOFF M.F. (1987) Interleukin 5 and interleukin 4 produced by Peyer's Patch T cells selectively enhane immunoglobilin A expression. J Immunol 139, 2669.
34. HARRIMAN G.R., KUNIMOTO O.R., ELLIOT J.F., PAETKAN V. & STROBER W. (1990) The role of IL-15 in IgA B cell differentiation. J Immunol 140, 3033.
35. MOSMANN P.D. & COFFMAN R.L. (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7, 145.
36. GRAHAM M.B., DALTON D., GILTINAN D., BRACIALE V.L., STEWART T.A. & BRACIALE T.J. (1993) Responses to influenza infection in mice with a targetted disruption in the interferon gamma gene. J Exp Med 178, 1725.
37. SCHARTON-KERSTEN T.M., WYNN T.A., DENKERS E.Y. (1996) et al. In the absence of endogenous IFNγ, mice develop unimpaired IL-12 responss to Toxoplasma gondii while failing to control accute infection. J Immunol 157, 4045.
38. JEONG G. (1995) Suppressed proliferation of mouse hepatoma cells by conditioned media from interferon treated hepatocytes. Biochem Mol Biol Internatl 36, 136.
39. HANSSON G.K., HELLSTRAND M., RYMO I., RUBBIA I. & GABBIANI G. (1989) Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 170, 1595.
40. + effector cells default to the TH2 pathway in IFNγ-deficient mice. FASEB J 8: A.250.
41. DALTON D.K., PITTS-MEEK S., KERSHAV S., FIGARI I.S., BRADLEY A. & STEWART T.A. (1993) Multiple defects of immune cell function in mice with disrupted interferon gamma genes. Science 259, 1739.
42. + TCR alpha-beta cells and IFN-γ in bacterial clearance independent of intracellular location. J Immunol 156, 3321.
43. SCHIJNS V.E.C.J., WIERDA C.M.H., VAN HOEIJ M. & HORZINCK M.C. (1996) Exacerbated viral hepatitis in IFNg receptor deficient mice is not suppressed by Il-1 Immunol 157, 815.
44. + T cell response. J Exp Med 181, 961.
45. RAMSAY A.J., HUSBAND A.J., RAMSHAW I.A. et al. (1994) The role of interleukin 6 in mucosal IgA antibody responses in vivo. Science 264, 561.
46. + T helper cell 1 development in interleukin 6 deficient mice infected with Candida albicans. J Exp Med 183, 1345.
47. BROMANDER A.K., EKMAN L. KOPF M., NEDRUD J.G. & LYCKE N.Y. (1996) IL-6 deficient mice exhibit normal mucosal IgA responses to local immunisations and Helicobacter felis infection. J Immunol 156, 4290.